Skip to main content

Table 1 Characteristics of patients

From: Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum

patient

age (years)

diagnosis

previous chemotherapy

regimen

timing of measurement after the first dose (days from start)

toxicity during first 6 weeks of therapy (grade)

baseline lactulose/mannitol ratio

lactulose/mannitol ratio after the first dose

1

52

EOC (history of BC)

yes

q3w (cisplatin)

6

diarrhea (2)

0.069

0.033

2

66

EOC

none

q3w

7

diarrhea (1)

0.030

0.011

3

67

EOC (history of BC)

none

q3w

7

none

0.096

0.047

4

46

EOC

yes

q3w

7

neutropenia (3)

0.027

0.079

5

52

EOC

none

q3w

7

none

0.017

0.017

6

39

unknown primary

none

q3w

6

none

0.044

0.021

7

39

Krukenberg

yes

q3w

7

diarrhea (3)

0.111

0.132

8

62

EOC (history of BC)

yes

q3w

4

none

0.090

0.018

9

71

EOC

yes

q3w

7

neutropenia (4)

0.108

0.770

10

67

EOC

none

q3w

7

leukopenia (2)

0.061

0.129

11

64

BC

yes

q3w

7

leukopenia (2)

0.041

0.144

12

56

EOC

yes

q3w

7

none

0.031

0.027

13

64

BC

yes

q3w

7

none

0.041

0.032

14

58

BC

yes

q3w

7

diarrhea (1)

0.026

0.132

15

60

BC

yes

q3w

7

none

0.033

0.054

16

45

BC

yes

q3w

7

none

0.033

0.110

17

54

BC

yes

q3w

7

nausea (3)

0.184

0.438

18

58

BC

yes

q3w

7

neutropenia (3)

0.038

0.057

19

61

unknown primary

none

q3w

6

diarrhea (2)

0.055

0.063

20

66

BC

yes

q3w

2

leukopenia (2)

0.031

0.040

21

46

EOC (history of BC)

none

q3w

7

none

0.047

0.029

22

52

EOC (history of BC)

yes

q3w

7

leukopenia (2)

0.063

0.119

23

59

BC

yes

weekly P+C+T

7

anemia (3)

0.072

0.094

24

78

BC

yes

weekly P+ T

7

diarrhea (3)

0.094

0.133

25

45

BC

yes

weekly P+C+T

7

none

0.069

0.128

26

63

BC

none

weekly P+C

7

none

0.075

0.060

27

36

Krukenberg

yes

weekly P+C

7

leukopenia (3)

0.072

0.106

28

57

BC

yes

weekly P+C+T

7

none

0.038

0.041

29

74

EOC

none

weekly P+C

2

nausea (3)

0.090

0.130

30

41

BC

yes

weekly P+C+T

22

neutropenia (4); stomatitis (3)

0.038

0.030

31

79

EOC

none

weekly P+C

3

nausea (3)

0.120

0.118

32

34

BC

yes

weekly P+C+T

7

none

0.025

0.010

33

63

BC

yes

weekly P+C+T

8

diarrhea (3)

0.075

0.070

34

55

BC

yes

weekly P+C+T

7

neutropenia (3)

0.043

0.069

35

62

BC

yes

weekly P+C+T

7

none

0.082

0.099

36

54

BC

yes

weekly P+C+T

7

none

0.030

0.044

  1. Grade 3 or 4 toxicity is highlighted by bold type. BC breast carcinoma; C carboplatin; EOC epithelial ovarian carcinoma; q3w paclitaxel/carboplatin every 3 weeks (cisplatin in patient 1); P paclitaxel; T trastuzumab